Pushkar Saralkar
Impact in
- Molecular Medicine top 10%
- Curcumin's Biomedical Applications
-
- Nanoparticle-Based Drug Delivery
Papers in
-
- Barrier Structure and Function Studies 2
- Co-authors
- Alekha K. DashWerner J. GeldenhuysPaul R. LockmanSamuel A. SprowlsTimothy E. LongTasneem ArsiwalaMark V. PintiNeal Shah
- Journals
- Pharmaceutical Research (2 papers)Experimental Neurology (1 paper)AAPS PharmSciTech (1 paper)European Journal of Medicinal Chemistry (1 paper)International Journal of Pharmaceutics (1 paper)
- Partner nations
- United StatesJapan
In The Last Decade
Pushkar Saralkar
15 papers receiving 407 citations
Peers
Comparison fields: 5 of 77
- Molecular Medicine 36
- Biomaterials 54
- Pharmaceutical Science 25
- Genetics 41
- Oncology 76
Countries citing papers authored by Pushkar Saralkar
This map shows the geographic impact of Pushkar Saralkar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pushkar Saralkar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pushkar Saralkar more than expected).
Fields of papers citing papers by Pushkar Saralkar
This network shows the impact of papers produced by Pushkar Saralkar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pushkar Saralkar. The network helps show where Pushkar Saralkar may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Pushkar Saralkar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 6 | |
| 2 | 2021 | 10 | |
| 3 | 2021 | 7 | |
| 4 | 2021 | 42 | |
| 5 | 2021 | 2 | |
| 6 | 2020 | 9 | |
| 7 | 2020 | 15 | |
| 8 | 2020 | 23 | |
| 9 | 2020 | 27 | |
| 10 | 2019 | 21 | |
| 11 | 2019 | 5 | |
| 12 | 2018 | 105 | |
| 13 | 2018 | 39 | |
| 14 | 2017 | 67 | |
| 15 | 2017 | 34 |
About Pushkar Saralkar
Pushkar Saralkar is a scholar working on Neurology, Physiology, Modeling and Simulation, Molecular Medicine and Clinical Biochemistry, having authored 15 papers that have together received 412 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (3 papers), Brain Metastases and Treatment (2 papers), Advanced Nanomaterials in Catalysis (2 papers), Barrier Structure and Function Studies (2 papers), Metalloenzymes and iron-sulfur proteins (2 papers), Lung Cancer Treatments and Mutations (2 papers), Fungal Plant Pathogen Control (1 paper) and Advanced Breast Cancer Therapies (1 paper). The work is most often cited by research in Molecular Medicine (36 citations), Biomaterials (54 citations), Pharmaceutical Science (25 citations), Genetics (41 citations) and Oncology (76 citations). Pushkar Saralkar has collaborated with scholars based in United States and Japan. Frequent co-authors include Alekha K. Dash, Werner J. Geldenhuys, Paul R. Lockman, Samuel A. Sprowls, Timothy E. Long, Tasneem Arsiwala, Mark V. Pinti, Neal Shah, Afroz S. Mohammad and Brandon Lucke‐Wold. Their work appears in journals such as Pharmaceutical Research, Experimental Neurology, AAPS PharmSciTech, European Journal of Medicinal Chemistry and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.